Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FR2YB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,116
Award facts
- Contract value 100% obligated
- $39,115.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,115.51 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on July 10, 2025, with completion targeted for July 11, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems. The place of performance is located at the company's corporate office in Conshohocken, PA.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award demonstrates AmerisourceBergen Drug Corp's established capability to fulfill federal pharmaceutical procurement requirements, with the company maintaining a robust portfolio of competitively awarded contracts spanning diabetes medications, specialty pharmaceuticals, and other critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FR2YB?
SPE2DB25FR2YB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FR2YB worth?
The government has obligated $39,116 on SPE2DB25FR2YB.
Is contract SPE2DB25FR2YB an order under another contract?
Yes. SPE2DB25FR2YB is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR2YB competed?
The extent of competition for SPE2DB25FR2YB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award